Detalhe da pesquisa
1.
Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis.
Pancreatology
; 22(1): 67-73, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774414
2.
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study.
BMC Gastroenterol
; 21(1): 94, 2021 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33653274
3.
Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis.
Liver Int
; 38(7): 1242-1252, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29235260
4.
Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections.
Liver Int
; 37(7): 1023-1031, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28109038
5.
Macrophage activation marker, soluble CD163, is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.
Liver Int
; 36(11): 1628-1638, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27031405
6.
[Intestinal fatty acid binding protein: marker of enterocyte damage in acute and chronic gastroenterological diseases]. / Intestinalis zsírsavköto fehérje: az enterocytakárosodás markere akut és krónikus gasztroenterológiai kórképekben.
Orv Hetil
; 157(2): 59-64, 2016 Jan 10.
Artigo
em Húngaro
| MEDLINE | ID: mdl-26726140
7.
High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
J Hepatol
; 59(3): 457-66, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23639483
8.
Improved body composition decreases the fat content in non-alcoholic fatty liver disease, a meta-analysis and systematic review of longitudinal studies.
Front Med (Lausanne)
; 10: 1114836, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37215704
9.
Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.
Clin Res Hepatol Gastroenterol
; 45(5): 101579, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773436
10.
Deleterious effect of proton pump inhibitors on the disease course of cirrhosis.
Eur J Gastroenterol Hepatol
; 32(2): 257-264, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464790
11.
Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
World J Gastroenterol
; 26(34): 5130-5145, 2020 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32982114
12.
Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation.
Thromb Haemost
; 118(8): 1397-1408, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29972862
13.
Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.
PLoS One
; 13(3): e0194166, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29590158
14.
Mucosal Autoimmunity to Cell-Bound GP2 Isoforms Is a Sensitive Marker in PSC and Associated With the Clinical Phenotype.
Front Immunol
; 9: 1959, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30233574
15.
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.
Sci Rep
; 8(1): 399, 2018 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29321484
16.
Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis.
World J Gastroenterol
; 23(29): 5412-5421, 2017 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28839442
17.
High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial.
BMJ Open
; 7(9): e015874, 2017 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28912191
18.
Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
World J Gastroenterol
; 22(41): 9172-9185, 2016 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895404
19.
Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].
J Crohns Colitis
; 9(8): 659-68, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25968583